Dear colleagues -
the FDA published several discussion papers on the use of AI in drug development and manufacturing. The development paper is attached. FDA has a lot of questions for input that span a wide area of the drug development trajectory. I am wondering how we can contribute to the conversation at AAPS. I am going to tag @Mark Arnold for bioanalytical and @Victoria Demby for clinical/reg thoughts but would love to hear what everybody is thinking about this.
Thanks,
Tina
------------------------------
Tina Morris Ph.D.
Executive Director
AAPS
Arlington VA
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------